Europe Rapid Diagnostic Tests (RDT) Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Dec 2021
  • Europe
  • 350 Pages
  • No of Tables: 309
  • No of Figures: 65

Europe Rapid Diagnostic Tests (RDT) Market, By Product Type (Consumables and Kits, Instruments and Others), Mode (Professional Rapid Diagnostic Test Product and Over-The-Counter [OTC] Rapid Diagnostic Test Product), Technology (PCR-Based, Flow-Through Assays, Lateral Flow Immunochromatographic Assays, Agglutination Assay, Microfluidics, Substrate Technology and Others), Modality (Laboratory Based Test and Non-Laboratory Based Test), Age Group (Adult and Pediatric), Test Type (Determining Confirmation, Serological Testing and Viral Sequencing), Approach (In-Vitro Diagnostic, Molecular Diagnostic), Specimen (Swab, Blood, Urine, Saliva, Sputum and Others), Application (Infectious Disease Testing, Glucose Monitoring, Cardiology Testing, Oncology Testing, Cardiometabolic Testing, Drugs-of-Abuse Testing, Pregnancy & Fertility Testing, Toxicology Testing, Others), End User (Hospital & Clinic, Diagnostic Laboratory, Home Care Setting, Research and Academic Institutes and Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe), Industry Trends and Forecast to 2029  

Europe Rapid Diagnostic Tests (RDT) Market Market Analysis and Insights: Europe Rapid Diagnostic Tests (RDT) Market

Europe rapid diagnostic tests (RDT) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.2% in the forecast period of 2022 to 2029 and is expected to reach USD 18,742.40 million by  2029 from USD 10,434.87 million in 2021. The rise in incidence in chronic diseases and technological advancements in rapid diagnostic tests are likely to be the major drivers which propel the demand of the market in the forecast period.

The rapid diagnostic tests, also called rapid tests, are easy-to-use tests that offer quick results, usually in less than 20 minutes. Unlike other standard and conventional tests, where the diagnosis and sampling are sent to the laboratory, the results obtained from rapid diagnostic test kits are provided at the point of care. The point of care is a place where the patients get cured. The point of care can be a provider’s office, a clinic, or a patient’s own house.

The RDTs are applicable for diagnosing and testing infectious diseases such as COVID-19, cardiology diseases, oncology, pregnancy, fertility testing, toxicology testing, drugs-of-abuse testing, cardiometabolic testing, and glucose monitoring.

The factors expected to drive the Europe rapid diagnostic tests (RDT) market are the increase in incidence in chronic diseases, rise in geriatric population, technological developments in the rapid diagnostic tests. However, the factors which are expected to restrain the market are the rise in the cost of rapid diagnostics, product recalls faced in rapid diagnostic tests, and lack of awareness about the use of rapid diagnostics. Moreover, the strategic initiatives by market players and the rise in healthcare expenditure are expected to create opportunities for the Europe rapid diagnostic tests (RDT) market growth. However, the need for skilled labor for sample collection and the late approval associated with product launches may significantly challenge market growth.

The Europe rapid diagnostic test (RDT) market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.  

Europe Rapid Diagnostic Tests (RDT) Market Europe Rapid Diagnostic Tests (RDT) Market Scope And Market Size

The Europe rapid diagnostic test (RDT) market is segmented based on product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the Europe rapid diagnostic tests (RDT) market is segmented into consumables and kits, instruments, and others. In 2022, the consumables and kits segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the availability of test kits and the increased use of ELISA in research laboratories in Europe.
  • On the basis of mode, the Europe rapid diagnostic tests (RDT) market is segmented into professional rapid diagnostic test product, and over-the-counter [OTC] rapid diagnostic test product. In 2022, the professional rapid diagnostic test product segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the presence of skilled professionals in Europe and increased demand for RDT for quick diagnosis and quick results for a specified disease.
  • On the basis of technology, the Europe rapid diagnostic tests (RDT) market is segmented into PCR-based, flow-through assays, lateral flow immunochromatographic assays, agglutination assay, microfluidics, substrate technology, and others. In 2022, the PCR-based segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to high throughput and accurate results obtained in PCR.
  • On the basis of modality, the Europe rapid diagnostic tests (RDT) market is segmented into laboratory based test and non-laboratory based test. In 2022, the laboratory based test segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the strict regulatory practices followed in laboratories while using the rapid diagnostic tests in Europe.
  • On the basis of age group, the Europe rapid diagnostic tests (RDT) market is segmented into adult and pediatric. In 2022, the adult segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the increase in the geriatric population in Europe and increase in life span.
  • On the basis of test type, the Europe rapid diagnostic tests (RDT) market is segmented into determining confirmation, serological testing, and viral sequencing. In 2022, the determining confirmation segment is expected to dominate the Europe rapid diagnostic tests (RDT) market since it is necessary to determine the cause of infectious diseases since the diagnosis by the RDTs provides confirmed results of the diagnosis of infectious disease.
  • On the basis of approach, the Europe rapid diagnostic tests (RDT) market is segmented into in-vitro diagnostic and molecular diagnostic. In 2022, the in-vitro diagnostic segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to its ability to detect infectious diseases and increased adoption of fully automated and point-of-care instruments in developed countries in Europe.
  • On the basis of specimen, the Europe rapid diagnostic tests (RDT) market is segmented into swab, blood, urine, saliva, sputum, and others. In 2022, the swab segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to its increased preference by the patients for testing and advancements in serology.
  • On the basis of application, the Europe rapid diagnostic tests (RDT) market is segmented into infectious disease testing, glucose monitoring, cardiology testing, oncology testing, cardiometabolic testing, drugs-of-abuse testing, pregnancy & fertility testing, toxicology testing, and others. In 2022, the infectious disease testing segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the rise in cases of chronic infectious disease and government funding in Europe for the use of rapid diagnostics.
  • On the basis of end user, the Europe rapid diagnostic tests (RDT) market is segmented into hospital & clinic, diagnostic laboratory, home care setting, research and academic institutes, and others. In 2022, the hospital and clinic segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the availability of advanced rapid diagnostic test (RDT)kits in hospitals based in Europe and the presence of advanced healthcare facilities.
  • On the basis of distribution channel, the Europe rapid diagnostic tests (RDT) market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the Europe rapid diagnostic tests (RDT) market due to the rise in contractual agreements between manufacturers and distributors for rapid diagnostic tests and equity in the tendering process.

 Europe Rapid Diagnostic Tests (RDT) Market Country Level Analysis

The Europe rapid diagnostic tests (RDT) market is analyzed, and market size information is provided by country, product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel.

The countries covered in the Europe rapid diagnostic tests (RDT) market report are the U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, and the Rest of Europe.

Europe is expected to grow with a high CAGR in the forecast period because of the growing R&D activities in the pulmonology segment. Germany is expected to dominate due to major market players and increased technological advancements of rapid diagnostic tests in the region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

Rise in Healthcare Expenditure for Rapid Diagnostic Tests in Emerging Countries in Europe and Strategic Initiatives by Market Players Create New Opportunities in Europe Rapid Diagnostic Tests (RDT) Market

The Europe rapid diagnostic tests (RDT) market also provides you with detailed market analysis for every country growth in a particular industry with Europe rapid diagnostic test sales, the impact of advancement in the Europe rapid diagnostic test and changes in regulatory scenarios with their support for the Europe rapid diagnostic tests (RDT) market. The data is available for the historical period 2011 to 2020.

Competitive Landscape and Europe Rapid Diagnostic Tests (RDT) Market Share Analysis

The Europe rapid diagnostic tests (RDT) market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company’s focus on the Europe rapid diagnostic tests (RDT) market.

Some of the major companies in the Europe rapid diagnostic tests (RDT) market are Abbott, Danaher, Cellex, Fujirebio (A Subsidiary of H.U. Group), Access Bio, Cardinal Health, Bio-Rad Laboratories, Inc., BD, F. Hoffmann-La Roche Ltd, bioMérieux SA, InBios International, Inc., Luminex Corporation. A DiaSorin Company, Gnomegen LLC, QIAGEN, Quidel Corporation, Chembio Diagnostics Systems, Inc., Sysmex Europe GmbH (A Subsidiary of Sysmex Corporation), Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG), MEGAKOR DIAGNOSTIK GMBH, PerkinElmer Inc., Sekisui Diagnostics, PTS Diagnostics, Werfen, Nova Biomedical, Trinity Biotech, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players and new technological advancements for the Europe rapid diagnostic tests (RDT) market bridge the gap for diagnosis and timely treatment for diseases.

For instance,

  • In April 2021, Siemens Healthcare GmbH launched the Atellica VTLi Patient-Side Immunoassay Analyzer, which had obtained the CE mark to diagnose a heart attack. The Atellica VTLi analyzer provides high-sensitivity cardiac troponin I test results to clinicians in eight minutes. The product launch would result in a rise in demand for the analyzer by clinicians and product expansion of the Atellica VTLi Patient-Side Immunoassay Analyzer in North America and Europe
  • In January 2021, the Quidel Corporation received the emergency product authorization from the Food and Drug Administration (FDA), for the Quickvue At-home COVID-19 test, for the qualitative detection of antigen from SARS-CoV-2. The product authorization received at an emergent time would result in timely detection and treatment of the patients, rise in demand for the at-home COVID-19 test among diagnostic specialists. The kit can also be used as a point of care device at home

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the Europe rapid diagnostic tests (RDT) market, which also benefits the organization to improve their offering for treatment products.

Customization Available: Europe Rapid Diagnostic Tests (RDT) Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 EUROPE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 EUROPE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 4 EUROPE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 EUROPE ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 EUROPE RT/PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 7 EUROPE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 EUROPE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 9 EUROPE OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 11 EUROPE PROFESSIONAL IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE OVER-THE-COUNTER [OTC] IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 14 EUROPE PCR-BASED IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 EUROPE FLOW-THROUGH ASSAYS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAYS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE AGGLUTINATION ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 20 EUROPE SUBSTRATE TECHNOLOGY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 23 EUROPE LABORATORY BASED TEST IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 EUROPE NON-LABORATORY BASED TEST IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 26 EUROPE ADULT IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE PEDIATRIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 29 EUROPE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 31 EUROPE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 EUROPE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 33 EUROPE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 35 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 36 EUROPE IN-VITRO DIAGNOSTIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 EUROPE MOLECULAR DIAGNOSTIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 39 EUROPE SWAB IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE BLOOD IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE URINE IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 EUROPE SALIVA IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 EUROPE SPUTUM IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 EUROPE OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 46 EUROPE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 EUROPE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 48 EUROPE GLUCOSE MONITORING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 EUROPE CARDIOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 EUROPE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 EUROPE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 52 EUROPE CARDIOMETABOLIC TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 53 EUROPE DRUGS-OF-ABUSE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 54 EUROPE PREGNANCY & FERTILITY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 EUROPE TOXICOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 56 EUROPE OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 57 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 58 EUROPE HOSPITAL & CLINIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 59 EUROPE DIAGNOSTIC LABORATORY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 60 EUROPE HOME CARE SETTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 61 EUROPE RESEARCH AND ACADEMIC INSTITUTES IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 62 EUROPE OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 63 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 64 EUROPE DIRECT TENDER IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 65 EUROPE RETAIL SALES IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 66 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 67 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 68 EUROPE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 69 EUROPE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 70 EUROPE ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 71 EUROPE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 72 EUROPE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 73 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 74 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 75 EUROPE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 76 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 77 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 78 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 79 EUROPE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 80 EUROPE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 81 EUROPE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 82 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 83 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 84 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 85 EUROPE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 86 EUROPE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 87 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 88 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 89 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 90 GERMANY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 91 GERMANY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 92 GERMANY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 93 GERMANY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 94 GERMANY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 95 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 96 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 97 GERMANY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 98 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 99 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 100 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 101 GERMANY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 102 GERMANY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 103 GERMANY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 104 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 105 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 106 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 107 GERMANY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 108 GERMANY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 109 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 110 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 111 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 112 FRANCE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 113 FRANCE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 114 FRANCE ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 115 FRANCE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 116 FRANCE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 117 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 118 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 119 FRANCE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 120 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 121 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 122 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 123 FRANCE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 124 FRANCE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 125 FRANCE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 126 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 127 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 128 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 129 FRANCE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 130 FRANCE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 131 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 132 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 133 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 134 U.K. CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 135 U.K. IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 136 U.K. ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 137 U.K. RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 138 U.K. INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 139 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 140 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 141 U.K. MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 142 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 143 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 144 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 145 U.K. DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 146 U.K. SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 147 U.K. VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 148 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 149 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 150 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 151 U.K. INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 152 U.K. ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 153 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 154 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 155 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 156 ITALY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 157 ITALY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 158 ITALY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 159 ITALY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 160 ITALY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 161 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 162 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 163 ITALY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 164 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 165 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 166 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 167 ITALY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 168 ITALY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 169 ITALY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 170 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 171 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 172 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 173 ITALY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 174 ITALY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 175 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 176 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 177 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 178 SPAIN CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 179 SPAIN IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 180 SPAIN ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 181 SPAIN RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 182 SPAIN INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 183 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 184 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 185 SPAIN MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 186 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 187 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 188 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 189 SPAIN DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 190 SPAIN SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 191 SPAIN VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 192 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 193 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 194 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 195 SPAIN INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 196 SPAIN ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 197 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 198 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 199 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 200 RUSSIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 201 RUSSIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 202 RUSSIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 203 RUSSIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 204 RUSSIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 205 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 206 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 207 RUSSIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 208 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 209 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 210 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 211 RUSSIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 212 RUSSIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 213 RUSSIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 214 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 215 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 216 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 217 RUSSIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 218 RUSSIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 219 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 220 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 221 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 222 TURKEY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 223 TURKEY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 224 TURKEY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 225 TURKEY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 226 TURKEY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 227 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 228 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 229 TURKEY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 230 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 231 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 232 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 233 TURKEY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 234 TURKEY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 235 TURKEY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 236 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 237 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 238 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 239 TURKEY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 240 TURKEY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 241 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 242 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 243 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 244 BELGIUM CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 245 BELGIUM IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 246 BELGIUM ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 247 BELGIUM RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 248 BELGIUM INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 249 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 250 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 251 BELGIUM MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 252 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 253 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 254 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 255 BELGIUM DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 256 BELGIUM SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 257 BELGIUM VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 258 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 259 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 260 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 261 BELGIUM INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 262 BELGIUM ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 263 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 264 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 265 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 266 NETHERLANDS CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 267 NETHERLANDS IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 268 NETHERLANDS ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 269 NETHERLANDS RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 270 NETHERLANDS INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 271 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 272 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 273 NETHERLANDS MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 274 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 275 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 276 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 277 NETHERLANDS DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 278 NETHERLANDS SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 279 NETHERLANDS VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 280 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 281 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 282 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 283 NETHERLANDS INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 284 NETHERLANDS ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 285 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 286 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 287 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 288 SWITZERLAND CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 289 SWITZERLAND IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 290 SWITZERLAND ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 291 SWITZERLAND RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 292 SWITZERLAND INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

TABLE 293 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2029 (USD MILLION)

TABLE 294 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 295 SWITZERLAND MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)

TABLE 296 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2029 (USD MILLION)

TABLE 297 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)

TABLE 298 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 299 SWITZERLAND DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 300 SWITZERLAND SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 301 SWITZERLAND VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)

TABLE 302 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2029 (USD MILLION)

TABLE 303 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2029 (USD MILLION)

TABLE 304 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 305 SWITZERLAND INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 306 SWITZERLAND ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

TABLE 307 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2029 (USD MILLION)

TABLE 308 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

TABLE 309 REST OF EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

Slides Slides Slides Slides Slides Slides